Gabriela Bleiber
- Infectious Diseases top 2%
- Virology top 0.5%
- Pharmacology top 1%
- Oncology top 10%
- Epidemiology
- Co-authors
- Amalio TelentiThierry BuclinHansjakob FurrerMargalida RotgerRaquel MartínezSara ColomboLaurent A. DécosterdHuldrych F. Günthard
- Topics
- HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (13 papers)Pharmacological Effects and Toxicity Studies (5 papers)
- Partner nations
- SwitzerlandUnited KingdomCzechia
In The Last Decade
Gabriela Bleiber
23 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 841
- Virology 830
- Pharmacology 271
- Oncology 261
- Epidemiology 244
Countries citing papers authored by Gabriela Bleiber
This map shows the geographic impact of Gabriela Bleiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriela Bleiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriela Bleiber more than expected).
Fields of papers citing papers by Gabriela Bleiber
This network shows the impact of papers produced by Gabriela Bleiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriela Bleiber. The network helps show where Gabriela Bleiber may publish in the future.
Co-authorship network of co-authors of Gabriela Bleiber
This figure shows the co-authorship network connecting the top 25 collaborators of Gabriela Bleiber. A scholar is included among the top collaborators of Gabriela Bleiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriela Bleiber. Gabriela Bleiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 63 | |
| 3 | 21 | |
| 4 | Abstract 205, 13th Conference on Retroviruses and Opportunistic Infections Denver, USA | 0 |
| 5 | 63 | |
| 6 | 90 | |
| 7 | 142 | |
| 8 | 52 | |
| 9 | 330 | |
| 10 | 27 | |
| 11 | 53 | |
| 12 | 20 | |
| 13 | 6 | |
| 14 | 84 | |
| 15 | 150 | |
| 16 | 40 | |
| 17 | 47 | |
| 18 | 68 | |
| 19 | 26 | |
| 20 | Heterogeneity in the response to antiretroviral therapy. | 4 |
About Gabriela Bleiber
Gabriela Bleiber is a scholar working on Virology, Infectious Diseases and Immunology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and Pharmacological Effects and Toxicity Studies (5 papers). The work is most often cited by research in Virology (830 citations), Infectious Diseases (841 citations) and Pharmacology (271 citations). Gabriela Bleiber has collaborated with scholars based in Switzerland, United Kingdom and Czechia. Frequent co-authors include Amalio Telenti, Thierry Buclin, Hansjakob Furrer, Margalida Rotger, Raquel Martínez, Sara Colombo, Laurent A. Décosterd, Huldrych F. Günthard, Jérôme Biollaz and Belle L. Lee. Their work appears in journals such as Clinical Infectious Diseases, Journal of Virology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.